394 related articles for article (PubMed ID: 25093216)
1. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
2. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
3. Subsequent primary cancers among men and women with in situ and invasive melanoma of the skin.
Balamurugan A; Rees JR; Kosary C; Rim SH; Li J; Stewart SL
J Am Acad Dermatol; 2011 Nov; 65(5 Suppl 1):S69-77. PubMed ID: 22018070
[TBL] [Abstract][Full Text] [Related]
4. Trends in the diagnosis and clinical features of melanoma in situ (MIS) in US men and women: A prospective, observational study.
Wei EX; Qureshi AA; Han J; Li TY; Cho E; Lin JY; Li WQ
J Am Acad Dermatol; 2016 Oct; 75(4):698-705. PubMed ID: 27436155
[TBL] [Abstract][Full Text] [Related]
5. Risk of Next Melanoma in Patients With Familial and Sporadic Melanoma by Number of Previous Melanomas.
Chen T; Fallah M; Försti A; Kharazmi E; Sundquist K; Hemminki K
JAMA Dermatol; 2015 Jun; 151(6):607-15. PubMed ID: 25671687
[TBL] [Abstract][Full Text] [Related]
6. Risk of second primary in situ and invasive melanoma in a Dutch population-based cohort: 1989-2008.
van der Leest RJ; Liu L; Coebergh JW; Neumann HA; Mooi WJ; Nijsten T; de Vries E
Br J Dermatol; 2012 Dec; 167(6):1321-30. PubMed ID: 22759226
[TBL] [Abstract][Full Text] [Related]
7. The acceleration of melanoma in situ: A population-based study of melanoma incidence trends from Victoria, Australia, 1985-2015.
Curchin DJ; Forward E; Dickison P; Harris VR; McCormack CJ; Smith SD
J Am Acad Dermatol; 2019 Jun; 80(6):1791-1793. PubMed ID: 31103160
[No Abstract] [Full Text] [Related]
8. Italian cancer figures, report 2013: Multiple tumours.
AIRTUM Working Group
Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Cutaneous Squamous Cell Carcinoma (cSCC) In situ Incidence and the Risk of Developing Invasive cSCC in Patients With Prior cSCC In situ vs the General Population in the Netherlands, 1989-2017.
Tokez S; Wakkee M; Louwman M; Noels E; Nijsten T; Hollestein L
JAMA Dermatol; 2020 Sep; 156(9):973-981. PubMed ID: 32609322
[TBL] [Abstract][Full Text] [Related]
10. Characterizing subsequent primary melanomas (SPM) in adolescents and young adults: A population-based study from 1973 to 2011.
Fu T; Swetter SM; Tao L; Geller AC; Clarke CA; Keegan TH
J Am Acad Dermatol; 2016 Jan; 74(1):181-182.e3. PubMed ID: 26702802
[No Abstract] [Full Text] [Related]
11. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
12. The incidence of second primary invasive melanoma in Queensland, 1982-2003.
McCaul KA; Fritschi L; Baade P; Coory M
Cancer Causes Control; 2008 Jun; 19(5):451-8. PubMed ID: 18167620
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis of an additional in situ melanoma does not influence survival for patients with a single invasive melanoma: A registry-based follow-up study.
Youlden DR; Khosrotehrani K; Green AC; Soyer HP; Kimlin MG; Youl PH; Aitken JF; Baade PD
Australas J Dermatol; 2016 Feb; 57(1):57-60. PubMed ID: 26776229
[TBL] [Abstract][Full Text] [Related]
14. Risk Factors of Subsequent Primary Melanomas in Austria.
Müller C; Wendt J; Rauscher S; Sunder-Plassmann R; Richtig E; Fae I; Fischer G; Okamoto I
JAMA Dermatol; 2019 Feb; 155(2):188-195. PubMed ID: 30566178
[TBL] [Abstract][Full Text] [Related]
15. Risk of Second Primary Cancer in Survivors of In Situ Melanoma.
Kimlin MG; Youlden DR; Brodie AM; DiSipio T; Youl P; Nair-Shalliker V; Baade PD
J Invest Dermatol; 2019 Apr; 139(4):842-847. PubMed ID: 30423330
[TBL] [Abstract][Full Text] [Related]
16. Second cancers following in situ carcinoma of the breast.
Franceschi S; Levi F; La Vecchia C; Randimbison L; Te VC
Int J Cancer; 1998 Jul; 77(3):392-5. PubMed ID: 9663601
[TBL] [Abstract][Full Text] [Related]
17. Multiple primary melanomas among 16,570 patients with melanoma diagnosed at Kaiser Permanente Northern California, 1996 to 2011.
Moore MM; Geller AC; Warton EM; Schwalbe J; Asgari MM
J Am Acad Dermatol; 2015 Oct; 73(4):630-6. PubMed ID: 26298295
[TBL] [Abstract][Full Text] [Related]
18. Incidence of invasive cancers following basal cell skin cancer.
Levi F; La Vecchia C; Te VC; Randimbison L; Erler G
Am J Epidemiol; 1998 Apr; 147(8):722-6. PubMed ID: 9554413
[TBL] [Abstract][Full Text] [Related]
19. Population-based 20-year survival among people diagnosed with thin melanomas in Queensland, Australia.
Green AC; Baade P; Coory M; Aitken JF; Smithers M
J Clin Oncol; 2012 May; 30(13):1462-7. PubMed ID: 22412152
[TBL] [Abstract][Full Text] [Related]
20. The systematic relationship between melanomas diagnosed in situ and when invasive.
Lee JA
Melanoma Res; 2001 Oct; 11(5):523-9. PubMed ID: 11595891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
